Restart Life Sciences Corp. (CSE:HEAL)

Restart Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.6	0.01	0.01	0.27	0.22
Short-Term Investments	0.05	0.16	-	-	-
Cash & Short-Term Investments	1.65	0.17	0.01	0.27	0.22
Cash Growth	872.37%	2001.30%	-96.97%	21.85%	-89.78%
Other Receivables	0.01	0.01	0.01	0.01	0.07
Receivables	0.01	0.01	0.01	0.01	0.07
Prepaid Expenses	0.1	-	0	0.01	0.04
Total Current Assets	1.76	0.18	0.02	0.28	0.33
Property, Plant & Equipment	0.01	0.01	0.01	0.01	0.02
Total Assets	1.77	0.19	0.03	0.3	0.88
Accounts Payable	0.23	0.19	0.39	0.12	0.4
Accrued Expenses	-	0.21	0.45	0.14	0.02
Short-Term Debt	0.25	0.08	-	-	-
Total Current Liabilities	0.48	0.49	0.84	0.26	0.42
Total Liabilities	0.48	0.49	0.84	0.26	0.42
Common Stock	53.38	50.52	50.19	50.07	48.37
Retained Earnings	-60.45	-59.06	-59.29	-58.06	-55.6
Comprehensive Income & Other	8.36	8.25	8.29	8.04	7.69
Shareholders' Equity	1.29	-0.3	-0.81	0.04	0.46
Total Liabilities & Equity	1.77	0.19	0.03	0.3	0.88
Total Debt	0.25	0.08	-	-	-
Net Cash (Debt)	1.41	0.09	0.01	0.27	0.22
Net Cash Growth	1535.88%	963.58%	-96.97%	21.85%	-89.78%
Net Cash Per Share	0.04	0.01	0.00	0.02	0.02
Filing Date Shares Outstanding	39.29	33.23	14.82	14.71	14.22
Total Common Shares Outstanding	39.29	18.01	14.72	14.51	11.15
Working Capital	1.28	-0.31	-0.82	0.03	-0.09
Book Value Per Share	0.03	-0.02	-0.06	0.00	0.04
Tangible Book Value	1.29	-0.3	-0.81	0.04	0.46
Tangible Book Value Per Share	0.03	-0.02	-0.06	0.00	0.04
Machinery	-	0.06	0.06	0.06	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.